CAMBRIDGE, Mass. (AP) _ Verve Therapeutics Inc. (VERV) on Monday reported a loss of $31.3 million in its fourth quarter.On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 65 cents.The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 54 cents per share.For the year, the company reported a loss of $120.3 million, or $4.48 per share._____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VERV at https://www.zacks.com/ap/VERV